Lakshman K Manjunath, MD
Cardiovascular Disease (Cardiology) · Dallas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Healthtexas Provider Network · 2,535 clinicians in this group
Hospitals listed: Baylor Scott & White Heart and Vascular Hospital · Baylor Scott & White Medical Center- Waxahachie · Baylor University Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Manjunath’s office at (469) 800-7700 to ask if they take your plan before you enroll.
State licence records
1 licence
- Texas S0329Physician License · since 2019 · expires 2027-02-28ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Baylor Scott & White Heart & Vascular Hospital - DallasDallas, TXAcute Care Hospital · Proprietary · Has an emergency departmentPart of Baylor Scott and White Health, which runs 31 hospitalsPatients rate it 4 of 5 · 87% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Baylor Scott & White Medical Center- WaxahachieWaxahachie, TXAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Baylor Scott and White Health, which runs 31 hospitalsPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Baylor University Medical CenterDallas, TXAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Baylor Scott and White Health, which runs 31 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.37 (1.18 to 1.56), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.96 (1.58 to 2.33) · 12,005 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.428, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.463, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.348, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.478, Oct 2024 – Sep 2025
See every measure and the patient survey for Baylor Scott & White Heart & Vascular Hospital - Dallas
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.29 (0.22 to 2.36) · 167 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.43 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 153 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 989 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.05 to 0.46) · 1,860 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.47) · 1,960 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (0.46 to 5.22) · 944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.35 (0 to 2.91) · 460 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.17 (0.69 to 3.64) · 953 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.46 (1.58 to 15.34) · 528 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.35 (0.39 to 8.31) · 502 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.39) · 930 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 240 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 35.5 · 138 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 191 cases | None | Jul 2022 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 326 cases | No different | Jan 2024 – Dec 2024 |
What patients said (647 patients answered, 24% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 71% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 90% |
| Patients who gave a rating of "9" or "10" (high) | 84% |
| Staff "always" explained new medications | 84% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 87% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 66% |
| "YES", patients would definitely recommend the hospital | 87% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Baylor Scott & White Medical Center- Waxahachie
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.08) · 734 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.67 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 154.74 (95.27 to 214.22) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 173 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.6 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.6 · 301 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 230 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.8 · 222 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,038 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.41) · 4,117 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.23 (1 to 5.46) · 794 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.57) · 753 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.95 (4.33 to 21.57) · 248 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.03 (2.04 to 10.03) · 215 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.28 (0.8 to 3.75) · 266 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.28) · 3,381 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.516 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 34 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 490 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.9 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.7 · 235 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 342 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.9 to 8.1) · 181 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.9 (9 to 15.7) · 181 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 369 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.1 to 15.7) · 922 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 234 cases | No different | Jan 2024 – Dec 2024 |
What patients said (589 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 67% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Baylor University Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 1 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.37 (1.18 to 1.56) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.96 (1.58 to 2.33) · 12,005 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.428 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.463 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.348 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.33 to 1.73) · 3,795 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 179.16 (144.76 to 213.56) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 254 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 144 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 389 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.8 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 643 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 5,849 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 12,485 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.02 to 0.36) · 13,415 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (2.56 to 5.38) · 4,364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.82 (0.66 to 2.98) · 2,261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.31 to 3.43) · 3,857 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.44 (4.94 to 11.94) · 2,072 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.5 (3.21 to 7.79) · 2,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.99 (0.7 to 3.28) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 117 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.258 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.932 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 92 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 895 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18.5 · 58 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -39 · 453 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.1 · 498 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 748 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.6 to 8.6) · 81 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.2 to 14.4) · 81 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 124 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.2 · 259 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 474 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.5 (11.4 to 18.4) · 1,313 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 743 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,542 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$140,078
Medicare paid this office $140,078 for 671 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 140 | $24,153 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | $19,444 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $15,732 | $128 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 305 | $15,643 | $50 |
| Return visit (30+ min) | 106 | $13,556 | $90 |
See all 28 services
| Long return visit (40+ min) | 140 | $24,153 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | $19,444 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $15,732 | $128 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 305 | $15,643 | $50 |
| Return visit (30+ min) | 106 | $13,556 | $90 |
| New patient visit (45+ min) | 86 | $9,573 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $5,477 | $88 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 205 | $4,341 | $12 |
| Ct scan of blood vessels and grafts of heart with contrast | 49 | $4,207 | $86 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $4,157 | $297 |
| Injection, octafluoropropane microspheres, per ml | 27 | $2,779 | $33 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $2,099 | $95 |
| Heart muscle strain imaging | 77 | $2,015 | $26 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $1,920 | $80 |
| Ultrasound of leg arteries at rest and after exercise | 15 | $1,780 | $119 |
| External shock to heart to regulate heart beat | 18 | $1,543 | $81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | $1,141 | $9 |
| Insertion of needle into vein for collection of blood sample | 78 | $813 | $9 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 13 | $799 | $61 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 15 | $711 | $47 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $307 | $13 |
| Ultrasound of heart, follow-up | 15 | $284 | $19 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $211 | $18 |
| Heart muscle strain imaging | 26 | $209 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 26 | $160 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 31 | $134 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $77 | $2 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $65 | $5 |
Who their Medicare patients are
671 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 15% · Women 55% · Also on Medicaid 11% · Health risk score 1.97. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Heart failure 45% · Diabetes 44% · Chronic kidney disease 44% · Atrial fibrillation 37% · Depression 30% · COPD 29% · Cancer 19% · Stroke 19% · Dementia 14%.
The office billed $592,378, Medicare allowed $185,012 and paid $140,078; for 2,321 services of 57 kinds; $3,101 of it was for drugs given in the office and $136,977 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 671 | 2,321 | 75 | 1.97 | $592,378 | $140,078 |
| 2023 | 129 | 315 | 75 | 1.76 | $111,308 | $26,433 |
| 2021 | 11 | 11 | 74 | 1.59 | $6,567 | $1,154 |
| 2020 | 105 | 184 | 71 | 3.50 | $47,474 | $17,671 |
| 2019 | 83 | 181 | 71 | 4.02 | $35,492 | $15,240 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $5,804 | $149 |
| New patient visit (45+ min) | 33 | $4,102 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $2,730 | $124 |
| Long return visit (40+ min) | 19 | $2,673 | $127 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $1,312 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $957 | $87 |
| Heart muscle strain imaging | 29 | $819 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $361 | $11 |
2020: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $8,823 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,769 | $151 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,132 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,362 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,934 | $161 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,626 | $86 |
Drugs they prescribed that Part D paid
$264,564
Pharmacies billed $264,564 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,359) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,121 generic and 238 brand-name prescriptions · $264,564 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 71 | $97,177 | $1,369 |
| Eliquis | 70 | $89,064 | $1,272 |
| Repatha Sureclick | 17 | $20,870 | $1,228 |
| Xarelto | 20 | $14,573 | $729 |
| Entresto | 21 | $14,322 | $682 |
See all 22 drugs
| Jardiance | 71 | $97,177 | $1,369 |
| Eliquis | 70 | $89,064 | $1,272 |
| Repatha Sureclick | 17 | $20,870 | $1,228 |
| Xarelto | 20 | $14,573 | $729 |
| Entresto | 21 | $14,322 | $682 |
| Praluent | 13 | $8,930 | $687 |
| Rosuvastatin | 289 | $3,470 | $12 |
| Dabigatran Etexilate | 16 | $2,231 | $139 |
| Metoprolol | 101 | $1,063 | $11 |
| Ezetimibe | 55 | $930 | $17 |
| Atorvastatin | 102 | $803 | $8 |
| Losartan | 84 | $710 | $8 |
| Carvedilol | 63 | $556 | $9 |
| Amiodarone | 34 | $514 | $15 |
| Spironolactone | 61 | $497 | $8 |
| Clopidogrel | 29 | $443 | $15 |
| Lisinopril | 38 | $363 | $10 |
| Furosemide | 58 | $267 | $5 |
| Losartan-Hydrochlorothiazide | 25 | $243 | $10 |
| Amlodipine Besylate | 30 | $223 | $7 |
| Metoprolol | 18 | $120 | $7 |
| Valsartan | 11 | $94 | $9 |
Year by year
| 2024 | 1,359 | 298 | 0% (0) | 18% | $264,564 |
| 2023 | 119 | 54 | 0% (0) | 19% | $34,631 |
| 2022 | 59 | 16 | 0% (0) | 25% | $14,632 |
| 2021 | 37 | 12 | 0% (0) | None | $7,592 |
| 2020 | 30 | 14 | None | None | $559 |
| 2019 | 41 | 24 | None | None | $2,448 |
| 2018 | 34 | 16 | 0% (0) | None | $5,669 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Jardiance | 13 | $21,397 | $1,646 |
| Atorvastatin | 24 | $360 | $15 |
| Metoprolol | 16 | $270 | $17 |
Money from drug and device companies
$518 in 2025
| 2025 | 6 | 29 | None | $518 |
| 2024 | 9 | 22 | None | $508 |
| 2023 | 7 | 8 | None | $292 |
| 2020 | 2 | 2 | None | $39 |
| 2019 | 5 | 8 | None | $124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Camzyos | $192 | 8 payments
|
| Novartis Pharmaceuticals | Leqvio | $182 | 14 payments
|
| Pfizer | Eliquis | $60 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $34 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Wainua | $33 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 1 payment
|
See all 29 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-16 | Camzyos | $1 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-16 | Camzyos | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-04 | Kerendia | $19 |
| Novartis Pharmaceuticals | Meals · 2025-12-03 | Leqvio | $18 |
| Novartis Pharmaceuticals | Meals · 2025-11-11 | Leqvio | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-29 | Eliquis | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-23 | Leqvio | $22 |
| Novartis Pharmaceuticals | Meals · 2025-10-23 | Leqvio | $0 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-16 | Lifevest | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-11 | Eliquis | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-05 | Kerendia | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Leqvio | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-13 | Camzyos | $18 |
| Novartis Pharmaceuticals | Meals · 2025-07-07 | Leqvio | $16 |
| Novartis Pharmaceuticals | Meals · 2025-06-24 | Leqvio | $2 |
| Novartis Pharmaceuticals | Meals · 2025-06-10 | Leqvio | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-14 | Camzyos | $16 |
| Novartis Pharmaceuticals | Meals · 2025-05-06 | Leqvio | $12 |
| Pfizer | Meals · 2025-05-01 | Eliquis | $22 |
| Novartis Pharmaceuticals | Meals · 2025-04-29 | Leqvio | $6 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-28 | Wainua | $33 |
| Novartis Pharmaceuticals | Meals · 2025-04-08 | Leqvio | $7 |
| Pfizer | Meals · 2025-03-26 | Eliquis | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-06 | Camzyos | $23 |
| Pfizer | Meals · 2025-03-05 | Eliquis | $18 |
| Novartis Pharmaceuticals | Meals · 2025-03-04 | Leqvio | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-24 | Camzyos | $76 |
| Novartis Pharmaceuticals | Meals · 2025-02-10 | Leqvio | $13 |
| Novartis Pharmaceuticals | Meals · 2025-01-22 | Leqvio | $5 |
See earlier years (2024, 2023, 2020, 2019)
2024: $508
| Pfizer | Vyndaqel | $181 | 11 payments
|
| Heartflow | Ffrct | $148 | 2 payments
|
| Recor Medical | Paradise Renal Denervation System | $52 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $50 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Amgen | Repatha | $16 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $15 | 1 payment
|
| Novo Nordisk | Ozempic | $15 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $14 | 1 payment
|
2023: $292
| Medtronic | Corevalve Evolut R | $139 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $43 | 2 payments
|
| ConvaTec | Aquacel Ag+ Extra | $28 | 1 payment
|
| Pfizer | Eliquis | $26 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $23 | 1 payment
|
| Amgen | Repatha | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $14 | 1 payment
|
2020: $39
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $22 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $17 | 1 payment
|
2019: $124
| CSL Behring | Kcentra | $47 | 3 payments
|
| Pfizer | Eliquis | $29 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $15 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $13 | 1 payment
|
Professional record
- NPI
- 1770939100
- Licence
- TX S0329Texas S0329: Active
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 3600 Gaston Ave Ste 550, Dallas, TX, 75246
- NPI first listed
- 2016-05-04
- NPI last updated
- 2024-01-24
- NPI record certified
- 2024-01-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Drive, Lane 154, Stanford, CA, 94305